Autologous Bone Marrow Mononuclear Cell Transplantation in Patients with Decompensated Alcoholic Liver Disease: A Randomized Controlled Trial

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Spahr, Laurent ^a   Chalandon, Yves ^a   Terraz, Sylvain ^a   Kindler, Vincent ^a   Rubbia Brandt, Laura ^a   Frossard, Jean Louis ^a   Breguet, Romain ^a   Lanthier, Nicolas ^a   Farina, Annarita ^a   Passweg, Jakob ^a   Becker, Christoph D ^a   Hadengue, Antoine ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CYTOKERATIN 7; INTERLEUKIN 6; KI 67 ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; ASCITES; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BRAIN HEMORRHAGE; CD34 SELECTION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; DRUG FATALITY; FEMALE; HEMATOMA; HEPATIC ENCEPHALOPATHY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTION; LENGTH OF STAY; LIVER BIOPSY; LIVER FAILURE; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER REGENERATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MULTIPLE ORGAN FAILURE; NEUTROPHIL CHEMOTAXIS; NONALCOHOLIC FATTY LIVER; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SCORING SYSTEM; SEPSIS; STEM CELL; STOMACH VARICES BLEEDING;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; CYTOKINES; FEMALE; HEPATIC ARTERY; HEPATOCYTES; HUMANS; LIVER; LIVER DISEASES, ALCOHOLIC; MALE; MIDDLE AGED; RECOVERY OF FUNCTION; REGENERATION; STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; YOUNG ADULT;

EID: 84872316109     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053719     Document Type: Article

References (47)

1. Jalan R, Gines P, Olson JC, Mookerjee RP, Moreau R, et al. (2012) Acute-on chronic liver failure. J Hepatol 57(6): 1336-1348.
2. Mathurin P, Mendenhall CL, Carithers RL Jr, Ramond MJ, Maddrey WC, et al. (2002) Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J Hepatol 36(4): 480-487.
3. Spahr L, Rubbia-Brandt L, Genevay M, Hadengue A, Giostra E, (2011) Early liver biopsy, intraparenchymal cholestasis, and prognosis in patients with alcoholic steatohepatitis. BMC Gastroenterol 11: 115.
4. EASL clinical practical guidelines, (2012) management of alcoholic liver disease. J Hepatol 57(2): 399-420.
5. Ramond MJ, Poynard T, Rueff B, Mathurin P, Theodore C, et al. (1992) A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 326(8): 507-512.
6. Gao B, Bataller R, (2011) Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141(5): 1572-1585.
7. Garg H, Kumar A, Garg V, Sharma P, Sharma BC, et al. (2012) Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure. Dig Liver Dis 44(2): 166-171.
8. Srikureja W, Kyulo NL, Runyon BA, Hu KQ, (2005) MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis. J Hepatol 42(5): 700-706.
9. Kamath PS, Kim WR, (2007) The model for end-stage liver disease (MELD). Hepatology 45(3): 797-805.
10. Sancho-Bru P, Altamirano J, Rodrigo-Torres D, Coll M, Millan C, et al. (2012) Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis. Hepatology 55(6): 1931-1941.
11. Fausto N, (2004) Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology 39(6): 1477-1487.
12. Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, et al. (2000) Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 6(11): 1229-1234.
13. Almeida-Porada G, Zanjani ED, Porada CD, (2010) Bone marrow stem cells and liver regeneration. Exp Hematol 38(7): 574-580.
14. Piscaglia AC, Shupe TD, Oh SH, Gasbarrini A, Petersen BE, (2007) Granulocyte-colony stimulating factor promotes liver repair and induces oval cell migration and proliferation in rats. Gastroenterology 133(2): 619-631.
15. Spahr L, Lambert JF, Rubbia-Brandt L, Chalandon Y, Frossard JL, et al. (2008) Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial. Hepatology 48(1): 221-229.
16. Garg V, Garg H, Khan A, Trehanpati N, Kumar A, et al. (2012) Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology, 142(3): 505-512 e501.
17. Houlihan DD, Newsome PN, (2008) Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroenterology 135(2): 438-450.
18. Kisseleva T, Brenner DA, (2012) The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis. J Hepatol 56(4): 965-972.
19. Horiguchi N, Ishac EJ, Gao B, (2007) Liver regeneration is suppressed in alcoholic cirrhosis: correlation with decreased STAT3 activation. Alcohol 41(4): 271-280.
20. Pai M, Zacharoulis D, Milicevic MN, Helmy S, Jiao LR, et al. (2008) Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol 103(8): 1952-1958.
21. Gordon MY, Levicar N, Pai M, Bachellier P, Dimarakis I, et al. (2006) Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells 24(7): 1822-1830.
22. Spahr L, Rubbia-Brandt L, Pugin J, Giostra E, Frossard JL, et al. (2001) Rapid changes in alcoholic hepatitis histology under steroids: correlation with soluble intercellular adhesion molecule-1 in hepatic venous blood. J Hepatol 35(5): 582-589.
23. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41(6): 1313-1321.
24. Roskams TA, Theise ND, Balabaud C, Bhagat G, Bhathal PS, et al. (2004) Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology 39(6): 1739-1745.
25. Farinati F, Cardin R, D'Errico A, De Maria N, Naccarato R, et al. (1996) Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation. Hepatology 23(6): 1468-1475.
26. Bernhard OK, Mathias RA, Barnes TW, Simpson RJ, (2011) A fluorescent microsphere-based method for assay of multiple analytes in plasma. Methods Mol Biol 728: 195-206.
27. Hillan KJ, Logan MC, Ferrier RK, Bird GL, Bennett GL, et al. (1996) Hepatocyte proliferation and serum hepatocyte growth factor levels in patients with alcoholic hepatitis. J Hepatol 24(4): 385-390.
28. Thenappan A, Li Y, Kitisin K, Rashid A, Shetty K, et al. (2010) Role of transforming growth factor beta signaling and expansion of progenitor cells in regenerating liver. Hepatology 51(4): 1373-1382.
29. Braun L, Mead JE, Panzica M, Mikumo R, Bell GI, et al. (1988) Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc Natl Acad Sci U S A 85(5): 1539-1543.
30. Fauser AA, Messner HA, (1979) Fetal hemoglobin in mixed hemopoietic colonies (CFU-GEMM), erythroid bursts (BFU-E) and erythroid colonies (CFU-E): assessment by radioimmune assay and immunofluorescence. Blood 54(6): 1384-1394.
31. Terai S, Ishikawa T, Omori K, Aoyama K, Marumoto Y, et al. (2006) Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 24(10): 2292-2298.
32. Yip WW, Burt AD, (2006) Alcoholic liver disease. Semin Diagn Pathol 23(3-4): 149-160.
33. Gilchrist ES, Plevris JN, (2010) Bone marrow-derived stem cells in liver repair: 10 years down the line. Liver Transpl 16(2): 118-129.
34. Lyra AC, Soares MB, da Silva LF, Braga EL, Oliveira SA, et al. (2010) Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study. Eur J Gastroenterol Hepatol 22(1): 33-42.
35. Amer ME, El-Sayed SZ, El-Kheir WA, Gabr H, Gomaa AA, et al. (2011) Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells. Eur J Gastroenterol Hepatol 23(10): 936-941.
36. Cui S, Hano H, Sakata A, Harada T, Liu T, et al. (1996) Enhanced CD34 expression of sinusoid-like vascular endothelial cells in hepatocellular carcinoma. Pathol Int 46(10): 751-756.
37. Katoonizadeh A, Nevens F, Verslype C, Pirenne J, Roskams T, (2006) Liver regeneration in acute severe liver impairment: a clinicopathological correlation study. Liver Int 26(10): 1225-1233.
38. Peng L, Xie DY, Lin BL, Liu J, Zhu HP, et al. (2011) Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes. Hepatology 54(3): 820-828.
39. Dalakas E, Newsome PN, Boyle S, Brown R, Pryde A, et al. (2010) Bone marrow stem cells contribute to alcohol liver fibrosis in humans. Stem Cells Dev 19(9): 1417-1425.
40. Ji SQ, Chen HR, Wang HX, Yan HM, Pan SP, et al. (2002) Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia. Biol Blood Marrow Transplant 8(5): 261-267.
41. Saito T, Okumoto K, Haga H, Nishise Y, Ishii R, et al. (2011) Potential therapeutic application of intravenous autologous bone marrow infusion in patients with alcoholic liver cirrhosis. Stem Cells Dev 20(9): 1503-1510.
42. Duncan AW, Dorrell C, Grompe M, (2009) Stem cells and liver regeneration. Gastroenterology 137(2): 466-481.
43. Fujii K, Ishimaru F, Kozuka T, Matsuo K, Nakase K, et al. (2004) Elevation of serum hepatocyte growth factor during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization. Br J Haematol 124(2): 190-194.
44. Jin SZ, Meng XW, Sun X, Han MZ, Liu BR, et al. (2010) Granulocyte colony-stimulating factor enhances bone marrow mononuclear cell homing to the liver in a mouse model of acute hepatic injury. Dig Dis Sci 55(10): 2805-2813.
45. Brunt EM, Walsh SN, Hayashi PH, Labundy J, Di Bisceglie AM, (2007) Hepatocyte senescence in end-stage chronic liver disease: a study of cyclin-dependent kinase inhibitor p21 in liver biopsies as a marker for progression to hepatocellular carcinoma. Liver Int 27(5): 662-671.
46. Chen J, Ishac EJ, Dent P, Kunos G, Gao B, (1998) Effects of ethanol on mitogen-activated protein kinase and stress-activated protein kinase cascades in normal and regenerating liver. Biochem J, 334 (Pt 3): 669-676.
47. Kiefer F, Helwig H, Tarnaske T, Otte C, Jahn H, et al. (2005) Pharmacological relapse prevention of alcoholism: clinical predictors of outcome. Eur Addict Res 11(2): 83-91.